home  about  experts  links
MPT WWW
 

Category: Consumer Driven Health Care

   The United States health care system ranks second to none in the quality of patient care for serious and life-threatening diseases, but we also have significant gaps in insurance coverage and financial incentives that drive up health care costs and encourage the overuse of certain types of care, including defensive medicine to ward off lawsuits. Public health care programs such as Medicare and Medicaid also suffer from substantial degrees of waste, fraud, and abuse, siphoning off scarce taxpayer funds that could be used for other priorities such as education or defense.

   Much of the waste and the high cost of health care can be attributed to the system of third-party payment for health care that has developed in this country since WWII. Third-party payment plans allow some consumers to use services without ever paying the full cost of health care utilization while others pay for benefits they don't need or want. The result is a system where health care costs spiral out of control and consumer choice is limited to the one or two insurance plans usually offered by employers. The Center for Medical Progress advocates for putting patients in charge of their own routine health care decisions and spending, reserving insurance for truly catastrophic injuries; and creating an interstate market for health insurance that encourages customized insurance plans and competition to provide high quality health care to all Americans.

[Spotlight] [Commentary] [Research] [Events] [News]


Commentary


Research


News

MPT on Twitter
MPT on Facebook

Conflict of Interest Regulation

Consumer Driven Health Care

Drug & Medical Device Innovation

Drug & Medical Device Litigation

FDA Regulation

Global Health

Health Care Policy

Intellectual Property
Rights & Innovation

Medicare and Medicaid

Personalized Medicine

Value of Medicine


NEW SECOND OPINION!
Experts Discuss Health Reform Legislation in Our "Second Opinion" Expert Forum!

Expert Panel:
  • Diana Furchtgott-Roth
  • David Gratzer
  • Douglas Holtz-Eakin
  • Tom Miller
  • Michael Tanner
  • Grace-Marie Turner

Click here to read their second opinions.

Project FDA.
  
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org